Detalhe da pesquisa
1.
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
Oncologist
; 2022 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445723
2.
Predictors of Progression in Barrett's Esophagus with Low-Grade Dysplasia: Results from a Multicenter Prospective BE Registry.
Am J Gastroenterol
; 112(6): 867-873, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28374813
3.
Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
J Am Acad Dermatol
; 85(4): 969-971, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493572
4.
Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms.
Haematologica
; 102(10): e384-e388, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596279
5.
Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys
; 114(2): 256-265, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675850
6.
Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.
Am J Hematol
; 91(12): E504-E505, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27581088
7.
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.
Clin Lymphoma Myeloma Leuk
; 18(10): 664-672.e2, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104176
8.
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.
Leuk Lymphoma
; 59(9): 2128-2134, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29320913